Hadassah

Shahar: Dawn of a New Healthy Life, Thanks to Hadassah’s Oncology Team

Thursday, Jul 31 2014

The difficult journey from a diagnosis of leukemia through life-saving treatment at the Hadassah Medical Center began for Shahar at about age six when she began to feel extremely tired in ballet class and found herself wanting to sleep an abnormal amount. Her father and mother, Amos and Esther Israel, took Shahar for many examinations. And then they discovered a lump.

Because Esther Israel is a cancer survivor herself and because Hadassah saved her life, she and Amos took Shahar to Hadassah, where she was cared for by Dr. Michael Weintraub, head of Pediatric Hemato-Oncology and his health care team. As he explains, when Shahar came to Hadassah, her life was in danger. She went through a very difficult time because the process toward cure is arduous for both the child and the parents. But, today, she is a healthy pre-teenager--free of leukemia.

Each year, Shahar (which means "dawn" in Hebrew) comes back to Hadassah’s pediatric oncology department to speak with parents and their children, providing wonderful, uplifting evidence of life after leukemia. As she says: "I dance; I have sports; I do everything; I am like a new Shahar"!

At Hadassah’s 2014 Convention this month, Shahar celebrated her Bat Mitzvah with the delegates in Las Vegas, Nevada. Watch below to meet Shahar and hear her story.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›
alt_text

Friday, Aug 2 2019

Eloxx Pharmaceuticals Announces New Drug Application for Clinical Trial in Cystic Fibrosis Patients

Professor Eitan Kerem, head of the Division of Pediatrics at the Hadassah Medical Organization, will serve as the Global Lead Investigator for this clinical trial.

READ MORE ›
alt_text

Wednesday, Jul 31 2019

Skin Cancer Treatment Enhanced in New Center for Dermatologic Surgery

Thanks to a donation by the Israeli businessman and philanthropist Morris Kahn, a major supporter of the Israeli moon spacecraft “Beresheet,” Hadassah Hospital Ein Kerem has just opened the new Center for Dermatologic Surgery, which offers Mohs surgery for patients with common types of skin cancer.

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More